Avalo Therapeutics (AVTX) FCF Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) FCF Margin (QoQ) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Avalo Therapeutics |
295.77 Mn |
295.77 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
-320,610.00 |
| Dec 31, 2023 |
241,220.00 |
| Sep 30, 2023 |
-118,184.00 |
| Jun 30, 2023 |
43,470.00 |
| Mar 31, 2023 |
-172,034.00 |
| Dec 31, 2022 |
-46,717.00 |
| Sep 30, 2022 |
125,063.00 |
| Jun 30, 2022 |
15,715.00 |
| Mar 31, 2022 |
644,305.00 |
| Dec 31, 2021 |
-660,012.00 |
| Sep 30, 2021 |
-64,077.00 |
| Jun 30, 2021 |
330,485.00 |
| Mar 31, 2021 |
-291,649.00 |
| Dec 31, 2020 |
11,382.00 |
| Sep 30, 2020 |
-43,469.00 |
| Jun 30, 2020 |
-43,100.00 |
| Mar 31, 2020 |
8,093.00 |
| Dec 31, 2019 |
5,686.00 |
| Sep 30, 2019 |
14,294.00 |
| Jun 30, 2019 |
-36,152.00 |
